drugset / Trial / NCT00453271
Treatment of Mild to Moderate Distal Subungual Onychomycosis of the Toenail
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of the study is to determine whether NB002, 0.25%, and 0.5% are safe and effective in the treatment of distal subungual onychomycosis of the toenail.
Timeline
- Start
- 2007-01
- Primary completion
- 2008-10
- Completion
- 2008-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cetylpyridinium | Small molecule | 0.25 % | — |
| Subject | Cetylpyridinium | Small molecule | 0.5 % | — |